American biotechnology company
China’s drugmakers can’t sell mRNA shots but haven’t quit yet | The Asahi Shimbun: Breaking News, Japan News and Analysis
asahi.com/ajw/articles/15235088
Moderna Pauses mRNA Plant Plans in Kenya After $1 Billion loss: Moderna Inc. has paused its efforts to build an mRNA manufacturing facility in Kenya while it ...
bloomberg.com/news/articles/2024-04-11/moderna-pauses-mrna-plant-plans-in-kenya-after-1-billion-loss
Paid articlePaid
Moderna pauses Kenya plant plans as COVID vaccine demand wanes: Moderna said on Thursday it had paused its plans to build a vaccine manufacturing facility in ...
reuters.com/business/healthcare-pharmaceuticals/moderna-puts-kenya-plant-plans-hold-covid-vaccine-demand-slumps-2024-04-11/
Pfizer wins pause on Moderna's COVID-19 patent lawsuit: Moderna's patent lawsuit claiming Pfizer and BioNTech copied its COVID-19 vaccine technology will be put ...
reuters.com/legal/litigation/pfizer-wins-pause-modernas-covid-19-patent-lawsuit-2024-04-12/
Influenza and coronavirus: one step closer to a combined vaccine: Moderna has been working for some time on the possibility of developing a vaccine that is ...
diepresse.com/18326862/influenza-und-corona-virus-einem-kombinierten-impfstoff-ein-stueck-naeher
Quick Glance: Advances in Combined Influenza and Covid-19 Vaccine
- Moderna progresses in developing a combined vaccine for Influenza and Covid-19.
- New Sars-CoV-2 vaccine elicits stronger immune response than current one.
- Study shows enhanced immune response in individuals over 65 years.
- Focus on targeted antibodies and extended vaccine shelf life in development.
Moderna jumps as vaccine shows benefit in head and neck cancer in early study: Moderna shares rose 8% to a three-month high on Tuesday after the company's ...
reuters.com/markets/us/moderna-jumps-personalized-cancer-vaccine-shows-benefit-early-study-2024-04-09/
State-of-the-Art Care in Amyotrophic Lateral Sclerosis: Improving Diagnostic Accuracy and Therapeutic Efficacy
medscape.org/viewarticle/999480
Nicole Shanahan, RFK Jr.’s Running Mate, Sets New Low for Anti-Vax Misinformation
thedailybeast.com/nicole-shanahan-rfk-jrs-running-mate-sets-new-low-for-anti-vax-misinformation
Paid articlePaid Moderna shares fall after judge sides with Arbutus in patent fight: Shares of Moderna fell 4% on Wednesday after a U.S. judge issued an order that strengthened ...
reuters.com/legal/moderna-shares-fall-after-judge-sides-with-arbutus-patent-fight-2024-04-03/
Were COVID-19 Vaccines to Blame for Infertility? Heart Attacks? A New Report Weighs In
usnews.com/news/health-news/articles/2024-04-16/were-covid-19-vaccines-to-blame-for-infertility-heart-attacks-a-new-report-weighs-in
Biontech: “Moderna has a one to two year lead when it comes to cancer drugs”: Biontech is working on over twenty drugs against cancer. The doctor and fund ...
wiwo.de/unternehmen/industrie/biontech-das-wuerde-ein-neues-zeitalter-in-der-krebstherapie-einleiten/29750834.html
Quick Glance: Innovative Cancer Therapy: Biontech's Advancement
- Biontech is actively developing over twenty cancer medications with promising results.
- Current developments and potential market introductions of cancer treatments.
- Significance of Biontech's promising results against pancreatic cancer.
The Dow drops 300 points as investors get jittery about inflation: Economists expect the consumer price index to increase from February
qz.com/dow-jones-industrial-average-inflation-fed-interest-rat-1851397283
The Dow struggles to recover as investors anxiously await inflation data — and the Fed
qz.com/dow-jones-inflation-report-consumer-price-index-1851398195
The top companies for training workers to use AI — including Amazon and GM: A new report reveals which firms are doing the most to advance AI literacy both ...
qz.com/amazon-gm-jpmorgan-moderna-ai-workforce-training-1851411624
Activist investor blasts Novavax for not using mRNA fears to boost COVID-19 vaccine sales
qz.com/novavax-covid19-mrna-1851410267
Quick Glance: Criticism of Novavax for Missed Opportunities in Boosting COVID-19 Vaccine Sales
- Shah Capital called for immediate changes in the company's board.
- The activist hedge fund Shah Capital criticized Novavax's leadership for not capitalizing on concerns some individuals have about mRNA vaccines to increase sales of its traditional, protein-based COVID-19 vaccine.
- Findings from a survey of 1,500 Americans by the Annenberg Public Policy Center (APPC) at the University of Pennsylvania revealed an increase in the spread of vaccine misinformation.
- The limited use of COVID-19 vaccines is also affecting other vaccine manufacturers. In the U.S., only 14% of adults have received an updated COVID-19 vaccine for 2023-2024, according to the Centers for Disease Control and Prevention.
Don't count us out yet, Novavax says: After losing the COVID vaccine race, it hopes a combination flu-COVID shot can help reverse its fortunes.
trib.al/B9FSzkd
Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug shortages: Pharma news round up
qz.com/moderna-cancer-vax-astrazeneca-ceo-pay-drug-shortages-1851404812
Moderna: Considering The Cancer Vaccine Angle: Moderna is developing a vaccine-based treatment for solid tumors. Read why I would not say that the oncology ...
seekingalpha.com/article/4683290-moderna-considering-the-cancer-vaccine-angle
Paid articlePaid
Markets in the morning: Moderna, Enphase, Rheinmetall, Daimler Truck, Vonovia, BP, Nordex, Nel, Freyr
Moderna’s stock up 6% as its cancer vaccine could treat more than just melanoma: Data shows a better overall survival rate for head and neck cancer in ...
marketwatch.com/story/modernas-stock-jumps-6-as-its-cancer-vaccine-could-treat-more-than-just-melanoma-92c8a45f
Mega potential: Will this biotech stock be as big as BioNTech and Moderna in their heyday?
boerse-online.de/nachrichten/aktien/mega-potenzial-wird-diese-biotech-aktie-so-gross-wie-biontech-und-moderna-zu-ihren-besten-zeiten--20354243.html
The Best Biotech Stocks to Buy: Thanks to rapid innovation and strong product launches, some biotech stocks look attractive again.
morningstar.com/stocks/best-biotech-stocks-buy
Ozempic's cheaper side, weight loss drug competition, and Amazon delivery: Pharma news roundup
qz.com/ozempic-weight-loss-drug-amazon-delivery-novo-nordisk-1851373018
Paid articlePaid
Blackstone to invest up to $750 million in Moderna: Moderna, one of the state’s largest biotechs, is trying to diversify its revenue stream after a global plunge ...
bostonglobe.com/2024/03/27/business/moderna-covid-vaccine-blackstone-flu-stephane-bancel/
The Best Biotech Stocks to Buy: Thanks to rapid innovation and strong product launches, some biotech stocks look attractive again.
morningstar.com/stocks/best-biotech-stocks-buy
Moderna secures $750 mn from Blackstone Life Sciences to develop flu shots: Blackstone Life Sciences will get commercial milestone payments and low-single digit ...
business-standard.com/companies/news/moderna-secures-750-mn-from-blackstone-life-sciences-to-develop-flu-shots-124032700714_1.html
COVID vaccines can cut post-infection heart failure, blood clot risk: Research: The COVID-19 vaccine can cut the risk of heart failure and blood clots after a ...
thehill.com/policy/healthcare/4541818-covid-vaccines-can-cut-post-infection-heart-failure-blood-clot-risk-research/
Moderna Stock Pops as New Covid-19 Vaccine Shows Positive Results: Moderna’s ‘next generation,’ Covid-19 vaccine has shown a higher immune response to the virus ...
barrons.com/articles/moderna-stock-pops-price-vaccine-55ef1af0
Paid articlePaid Moderna Gets $750 Million for Flu Program. Funding to Help Move Beyond Covid Vaccines.
on.barrons.com/43Csi93
Transcript: Moderna's CFO on What a Biotech Company Does with $13 Billion: Allocating Capital on a long and uncertain timeline
bloomberg.com/news/articles/2024-03-11/transcript
Paid articlePaid
Is Cathie Wood Buying The Rumor? Ark More Than Doubles Stake In This COVID-19 Vaccine Maker Ahead Of Flur
benzinga.com/general/biotech/24/03/37864820/is-cathie-wood-buying-the-rumor-ark-more-than-doubles-stake-in-this-covid-19-vaccine-maker-ahead-
Ozempic's cheaper side, weight loss drug competition, and Amazon delivery: Pharma news roundup
qz.com/ozempic-weight-loss-drug-amazon-delivery-novo-nordisk-1851373018
Paid articlePaid
COVID-19 timeline: How the deadly virus and the world's response have evolved over 4 years
abcnews.go.com/Health/covid-19-timeline-deadly-virus-worlds-response-evolved/story
$MRNA - Moderna, Inc. 2024 Q4 - Results - Earnings Call Presentation. seekingalpha.com/article/4672321-moderna-inc-2024-q4-results-earnings-call-presentation?source=feed_f&utm_campaign=twitter_automated&utm_content=article&utm_medium=social&utm_source=twitter_automated #markets #stocks #stockmarket
Largest-ever Covid vaccine study links Pfizer, Moderna and AstraZeneca to heart and brain disorders
.
.
.#Covid19 #CovidVaccine #Vaccine #Covid
Moderna’s Earnings Surprised the Street. Why One Analyst Says to Sell.: HBSC downgraded the vaccine maker to Reduce from Hold in a Monday report.
barrons.com/articles/moderna-stock-rsv-downgrade-cdc-6efafb59
Paid articlePaid Nvidia, Walmart, Moderna, Block, Newmont, and More Stocks to Watch This Week: The market is closed for Presidents Day on Monday. Then, Nvidia earnings ...
barrons.com/articles/nvidia-walmart-moderna-block-newmont-stocks-earnings-76eb184e
Paid articlePaid Moderna reports surprise profit, sets out road map for RSV vaccine: Moderna on Thursday reported a surprise fourth-quarter profit, helped by cost cutting and ...
reut.rs/49KcUcy
Covid Vaccines Linked To Small Increase In Heart And Brain Disorders, Study Finds—But Risk From Infection Is Far Higher
forbesafrica.com/health/2024/02/21/covid-vaccines-linked-to-small-increase-in-heart-and-brain-disorders-study-finds-but-risk-from-infection-is-far-higher/
99 million vaccinated people analyzed: Most common side effects of the corona vaccination
focus.de/gesundheit/news/99-millionen-probanden-grosse-studie-identifiziert-die-haeufigsten-nebenwirkungen-der-corona-impfung_id_259695927.html
Moderna’s RSV Vaccine May Lose Efficacy Faster Than GSK and Pfizer’s: Moderna shares were falling after the biotech revealed data that might hurt its vaccine’s ...
barrons.com/articles/moderna-stock-price-rsv-vaccine-b5d93bf3
Paid articlePaid
Closing bell: US stock markets turn up at the end of trading, Moderna accelerates - Merck & Co at the top of the Dow
deraktionaer.de/artikel/maerkte-forex-zinsen/schlussglocke-us-boersen-drehen-zum-handelsende-auf-moderna-gibt-gas-merck-co-an-dow-spitze-20353982.html
Moderna Is Pivoting From Covid—the Results Are on Their Way: An approved RSV vaccine on the market this year looks likely, but investors worry about efficacy.
on.wsj.com/3wtrR4I
DAX in record mode: SMA Solar, Rheinmetall, Renk, Moderna, Deutsche Bank, SGL and Airbus in focus
deraktionaer.de/artikel/indizes/dax-im-rekordmodus-sma-solar-rheinmetall-renk-moderna-deutsche-bank-sgl-und-airbus-im-fokus-20353876.html
Does she know more? Star investor Cathie Wood has just signed up for this BioNTech competitor
boerse-online.de/nachrichten/aktien/weiss-sie-mehr-bei-diesem-biontech-konkurrent-hat-cathie-wood-gerade-zugeschlagen-20353621.html
Moderna CEO Stephane Bancel joined CNBC’s “Squawk Box” Thursday to discuss the company’s quarterly earnings results, what’s in the company’s drug pipeline ... Show more cnb.cx/3ONQkYQ
If tech runs out of steam: That's why stocks from BioNTech and Co. are also exciting for investors
boerse-online.de/nachrichten/zertifikate/falls-tech-die-luft-ausgeht-darum-sind-auch-aktien-von-biontech-und-co-fuer-anleger-spannend-20353073.html
@ArenaMRV is the most beautiful in the world! 🏟️👏
Our venue surpassed 34 newly opened stages and won the 2023 stadium of the year award ... Show more
The UK could be a vaccine superpower, but it needs a booster: We risk forgetting the lessons of the Covid pandemic
ft.com/content/77f1be71-dc25-48df-8f9a-f677e2cf07a6
Paid articlePaid Moderna shares accelerate: That's the reason: That inspires you to start the week.
deraktionaer.de/artikel/pharma-biotech/moderna-aktie-gibt-maechtig-gas-das-ist-der-grund-20352636.html
Cancer vaccine being trialled by NHS could herald ‘dawn of a new age’ of treatments
independent.co.uk/news/health/cancer-vaccine-trials-nhs-moderna-b2489999.html
Cancer vaccines could be ‘dawn of a new age’ of treatments says Moderna chief: Dr Kyle Holen said he is excited about the future direction of treating the ...
inews.co.uk/news/cancer-vaccines-could-be-dawn-of-a-new-age-of-treatments-says-moderna-chief-2888584
Hamburg doctors see breakthrough in anti-cancer syringe: Biontech's coronavirus vaccine is being prepared for a syringe in a doctor's surgery in Hamburg (archive ...
abendblatt.de/hamburg/politik/article241761192/Hamburger-Aerzte-sehen-Durchbruch-bei-Spritze-gegen-Krebs.html
Paid articlePaid
Pharmaceutical industry: Moderna makes billions in losses, but the shares are rising
handelsblatt.com/unternehmen/industrie/pharma-branche-moderna-macht-milliardenverlust-doch-die-aktie-steigt/100017428.html
Moderna will supply COVID-19 vaccines made in Laval by fall 2025: The plant, whose construction was just completed, will be able to produce 100 million doses of ...
montrealgazette.com/news/local-news/moderna-will-supply-covid-19-vaccines-made-in-laval-by-fall-2025
Paid articlePaid DAX reaches new all-time high according to Nvidia figures, Nikkei with new record: SAP, MTU, Heidelberg Materials, SFC Energy, Gerresheimer, Mercedes-Benz ...
deraktionaer.de/artikel/indizes/dax-nach-nvidia-zahlen-vor-neuem-allzeithoch-nikkei-mit-neuem-rekord-sap-mtu-heidelberg-materials-sfc-energy-gerresheimer-mercedes-benz-moderna-und-hochtief-im-fokus-das-ist-heute-wichtig-20351077.html
Awesome trading week ahead: Despite a shortened US trading week, investors have their hands full with a variety of earnings reports from various sectors.
deraktionaer.de/artikel/maerkte-forex-zinsen/hammer-handelswoche-voraus-20350842.html
With Moderna and AstraZeneca: This biotech fund has gained over 900% in the last 20 years
boerse-online.de/nachrichten/fonds/mit-moderna-und-astrazeneca-dieser-biotech-fonds-hat-in-den-letzten-20-jahren-ueber-900-zugelegt-20350596.html
New mRNA cancer vaccine from Moderna trialled in British patients: Experts believe these vaccines may lead to a new generation of ‘off-the-shelf’ cancer ...
expressandstar.com/news/uk-news/2024/02/04/new-mrna-cancer-vaccine-from-moderna-trialled-in-british-patients/
Quick Glance: Global Cancer Burden and Urgent Service Needs
- Latest global cancer burden estimates released by WHO's IARC ahead of World Cancer Day.
- Survey in 115 countries shows inadequate funding for cancer and palliative care services.
- IARC's 2022 estimates highlight the growing burden of cancer and the urgent need to address global inequities.
- An estimated 20 million new cancer cases and 9.7 million deaths were recorded in 2022.
Developer bows out of Oakland apartment project amid market distress: Oakland’s apartment market is struggling amid softening demand and rents — and too much ...
sfchronicle.com/realestate/article/1940-webster-oakland-18656389.php
Paid articlePaid Like Pfizer and BioNTech, the biotechnology company Moderna is struggling with the post-corona period. Investors should be prepared for uncomfortable quarterly ... Show more ow.ly/81PF50QyO1n
Covid vaccine for pregnant women 'safe for newborn infants': Mothers being immunised was found to cut the risk of babies developing serious neonatal ...
thenationalnews.com/health/2024/02/06/covid-vaccine-for-pregnant-women-safe-for-newborn-infants/
Pharmacies in talks to expand rollout of high street Covid jabs: Superdrug and Boots are in talks with suppliers about offering the jab privately following news ...
inews.co.uk/news/health/pharmacies-high-street-covid-jabs-2885988
Medigen to publish COVID-19 research on U.S. journal - Focus Taiwan: Taipei, Feb. 2 (CNA) A COVID-19 vaccine research from Taiwan-based Medigen Vaccine Biologics ...
focustaiwan.tw/sci-tech/202402020014
Coming Soon: The First mRNA Vaccine for Melanoma?: Results of a phase 2b trial were favorable, and Moderna suggests that an mRNA vaccine for melanoma could be ...
medscape.com/viewarticle/coming-soon-first-mrna-vaccine-melanoma-2024a100014y
Alleged vaccine damage: First proceedings opened in Hesse against Biontech: Vaccinated people all over Germany are suing pharmaceutical companies because of ...
faz.net/aktuell/rhein-main/frankfurt/vermeintliche-impfschaeden-erstes-verfahren-in-hessen-gegen-biontech-eroeffnet-19469214.html
Paid articlePaidQuick Glance: Lawsuit Against Biontech for Alleged Vaccine Injuries
- Vaccinated individuals across Germany are suing pharmaceutical companies for alleged vaccine injuries.
- The first lawsuit against Biontech in Hessen has commenced in Frankfurt.
- The Frankfurt Regional Court heard a civil lawsuit against vaccine manufacturer Biontech on Tuesday.
- Lawyers represent nearly 3000 cases of alleged vaccine injuries and lawsuits.
Vaccine development beyond COVID needs more investment, BIO says: Even with the historic effort to develop COVID-19 vaccines, drug makers developing new vaccines ...
bostonglobe.com/2024/01/25/business/vaccine-development-investment-bio/
Moderna says it hit its 2023 COVID vaccine sales goal: Moderna (MRNA.O) on Monday said its 2023 COVID vaccine sales would be around $6.7 billion ...
reuters.com/business/healthcare-pharmaceuticals/modernas-2023-prelim-covid-vaccine-sales-meet-target-2024-01-08/
Short Sellers Lost on Tesla, Nvidia Stocks, Won on First Republic, Moderna: Regional banks and vaccine makers were among the few bright spots for short sellers ...
bloomberg.com/news/articles/2024-01-04/shorts-lost-195-billion-in-2023-despite-wins-on-regional-banks
Paid articlePaid
11 Stocks Are Taking Off Already — And The Year Just Started: The calendar just flipped to 2024 — and investors already have their favorite S&P 500 stocks ...
investors.com/etfs-and-funds/sectors/sp500-stocks-are-taking-off-already-and-the-year-just-started/
Short Sellers Lost on Tesla, Nvidia Stocks, Won on First Republic, Moderna: Regional banks and vaccine makers were among the few bright spots for short sellers ...
bloomberg.com/news/articles/2024-01-04/shorts-lost-195-billion-in-2023-despite-wins-on-regional-banks
Paid articlePaid
Biotech production: Wuxi is competing with Lonza and Siegfried: As a partner of Moderna, Lonza ensured the rapid production of vaccines during the pandemic ...
nzz.ch/meinung/biotech-produktion-wuxi-macht-lonza-und-siegfried-konkurrenz-ld.1773757
Moderna jumps on Oppenheimer upgrade, 2025 sales growth goal: Moderna (MRNA.O) shares gained nearly 14% on Tuesday as brokerage Oppenheimer upgraded the stock to ...
reuters.com/business/healthcare-pharmaceuticals/moderna-surges-after-ceo-says-sales-growth-expected-2025-2024-01-02/
Quick Glance: Over 100 Killed in 'Terrorist Attacks' near Tomb of Iranian Guards' Soleimani
- Two explosions at ceremony in Kerman, Iran, kill over 100 and injure many more.
- Iranian officials blame unspecified 'terrorists' for remotely detonated explosive attacks.
- At least 103 dead and 211 injured; one of the worst attacks in Iran.
- Cemetery evacuated and closed; Iran threatens strong response to the crimes.
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics